Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by brain cancer and perhaps other maladies affecting that organ.

12 Sep 2012

Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance

Massachusetts Eye and Ear and the Joslin Diabetes Center announced today that they have reached agreement to form a clinical and research alliance, aimed toward providing coordinated high quality care to eye patients throughout greater Boston, especially those with or at-risk for diabetes-related eye disease.

11 Sep 2012

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data are from one of the longest, continuously-dosed, placebo-controlled trials of a sleep medication ever conducted.

10 Sep 2012

UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa

Efforts to begin human clinical trials using stem cells to treat Alzheimer's disease and retinitis pigmentosa received a $37.3 million boost from the California Institute for Regenerative Medicine during its most recent round of funding on Sept. 5.

10 Sep 2012

Omeros files OMS824 IND with FDA to initiate clinical trials for cognitive disorders

Omeros Corporation today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate clinical trials evaluating OMS824, the Company's lead compound from its phosphodiesterase 10 (PDE10) program for schizophrenia and other cognitive disorders.

6 Sep 2012

DuraSite 2 ophthalmic drug delivery system from InSite Vision

InSite Vision Incorporated today introduced DuraSite 2, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics.

6 Sep 2012

Scientists identify three new genes associated with Primary Angle Closure Glaucoma

Singapore scientists have identified three new genes associated with Primary Angle Closure Glaucoma (PACG), a leading cause of blindness in Chinese people. PACG affects 15 million people worldwide, 80% of whom live in Asia.

5 Sep 2012

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Global ophthalmic company OptiMedica Corp. has announced U.S. Food and Drug Administration 510(k) market clearance of its Catalys Precision Laser System for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

5 Sep 2012

Useful vision maintained long term after lens-sparing vitrectomy for ROP

Infants treated with lens-sparing vitrectomy for retinopathy of prematurity maintain a level of visual acuity necessary for useful vision into their eighth year of life, study results show.

31 Aug 2012

Tips for parents to help their kids get a smart start to the academic year

The first day of school always requires preparations -- notebooks, pens and a new set of clothes. But don't forget to prepare for your child's health, says Dr. Joan Bregstein, a physician in the Division of Pediatric Emergency Medicine at NewYork-Presbyterian/Morgan Stanley Children's Hospital.

30 Aug 2012

Researchers develop glue mixture that may reduce risks after laser vision correction surgery

Kansas State University researchers have developed a glue mixture that may reduce risks after laser vision correction surgery.

28 Aug 2012

'ESASO Course Series’ for ophthalmologists

In the new book series 'ESASO Course Series', the essentials of the courses of the European School for Advanced Studies in Ophthalmology (ESASO) are made available to interested ophthalmologists, optometrists, technicians and residents all over the world.

23 Aug 2012

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

21 Aug 2012

Ophthalmology News and Research

Further Reading

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance

Phase III data for Suvorexant, an investigational insomnia medicine, announced

UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa

Omeros files OMS824 IND with FDA to initiate clinical trials for cognitive disorders

DuraSite 2 ophthalmic drug delivery system from InSite Vision

Scientists identify three new genes associated with Primary Angle Closure Glaucoma

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Useful vision maintained long term after lens-sparing vitrectomy for ROP

Tips for parents to help their kids get a smart start to the academic year

Researchers develop glue mixture that may reduce risks after laser vision correction surgery

'ESASO Course Series’ for ophthalmologists

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Study identifies mode of death of cone photoreceptor cells in animal model of RP

Overcorrection is a risk in pediatric exotropia surgery

Lucentis receives FDA approval for treatment of diabetic macular edema

Worldwide data reveal gaps in elderly eye care

Plasma exchange is beneficial additive to optic neuritis treatment

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

Researchers develop blue light to help manage internal clocks of night workers

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News